Equities

Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)850.55
  • Today's Change0.55 / 0.06%
  • Shares traded44.18k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2,8781,5051,033
Total Receivables, Net10,0329,84410,293
Total Inventory6,3047,2987,224
Prepaid expenses1279179
Other current assets, total67504287
Total current assets19,40919,24218,916
Property, plant & equipment, net13,77211,92510,439
Goodwill, net212121
Intangibles, net695956
Long term investments3878164
Note receivable - long term295708638
Other long term assets278267234
Total assets35,16432,66530,690
LIABILITIES
Accounts payable5,3215,6715,897
Accrued expenses488371333
Notes payable/short-term debt3,6773,9133,427
Current portion long-term debt/capital leases513412133
Other current liabilities, total2,1062,2892,934
Total current liabilities12,10612,65612,724
Total long term debt1,4621,904437
Total debt5,6526,2293,998
Deferred income tax122253393
Minority interest1106232
Other liabilities, total14,27010,61910,884
Total liabilities28,06925,49324,471
SHAREHOLDERS EQUITY
Common stock286286143
Additional paid-in capital1,2721,2721,272
Retained earnings (accumulated deficit)5,5375,6144,805
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity7,0957,1726,220
Total liabilities & shareholders' equity35,16432,66530,690
Total common shares outstanding157157157
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.